The global durable medical equipment market size was USD 195.04 billion in 2023, calculated at USD 206.74 billion in 2024 and is projected to surpass around USD 370.24 billion by 2034, expanding at a CAGR of 6% from 2024 to 2034.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Durable Medical Equipment Market, by Product Type, 2024-2034
7.1.1. Personal Mobility Devices
7.1.1.1. Market Revenue and Forecast (2021-2034)
7.1.2. Monitoring and Therapeutic Devices
7.1.2.1. Market Revenue and Forecast (2021-2034)
7.1.3. Bathroom Safety Devices
7.1.3.1. Market Revenue and Forecast (2021-2034)
7.1.4. Medical Furniture
7.1.4.1. Market Revenue and Forecast (2021-2034)
7.1.5. Incontinent Pads
7.1.5.1. Market Revenue and Forecast (2021-2034)
7.1.6. Breast Pumps
7.1.6.1. Market Revenue and Forecast (2021-2034)
7.1.7. Catheters
7.1.7.1. Market Revenue and Forecast (2021-2034)
7.1.8. Consumables and Accessories
7.1.8.1. Market Revenue and Forecast (2021-2034)
7.1.9. Others
7.1.9.1. Market Revenue and Forecast (2021-2034)
8.1. Durable Medical Equipment Market, by End-use, 2024-2034
8.1.1. Hospitals
8.1.1.1. Market Revenue and Forecast (2021-2034)
8.1.2. Home Healthcare
8.1.2.1. Market Revenue and Forecast (2021-2034)
8.1.3. Ambulatory Surgical Centers
8.1.3.1. Market Revenue and Forecast (2021-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.2. Market Revenue and Forecast, by End-use (2021-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.1.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.2.6.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.3.6.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.4.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2021-2034)
9.4.6.2. Market Revenue and Forecast, by End-use (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.2. Market Revenue and Forecast, by End-use (2021-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.3.2. Market Revenue and Forecast, by End-use (2021-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2021-2034)
9.5.4.2. Market Revenue and Forecast, by End-use (2021-2034)
10.1. ArjoHuntleigh
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Becton
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Dickinson and Company
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. General Electric Company
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. GF Health Products Inc.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Hill-Rom Services Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Invacare Corporation
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Koninklijke Philips NV
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Medical Device Depot Inc.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Medline Industries Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample